Insider Transactions in Q3 2019 at Onconova Therapeutics, Inc. (ONTX)
Insider Transaction List (Q3 2019)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Sep 24
2019
|
Tyndall Capital Partners L P > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
33,400
-2.64%
|
$33,400
$1.19 P/Share
|
Sep 23
2019
|
Tyndall Capital Partners L P > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
37,242
-5.56%
|
$37,242
$1.23 P/Share
|
Sep 23
2019
|
Armistice Capital, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
0
|
-
|
Sep 23
2019
|
Armistice Capital, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
10,249
-1.24%
|
$10,249
$1.27 P/Share
|
Sep 20
2019
|
Tyndall Capital Partners L P > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
75,119
-10.08%
|
$75,119
$1.62 P/Share
|
Sep 18
2019
|
Tyndall Capital Partners L P > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
49,995
-6.29%
|
$99,990
$2.1 P/Share
|
Sep 18
2019
|
683 Capital Management, LLC |
SELL
Open market or private sale
|
Indirect |
506,877
-13.44%
|
$1,013,754
$2.05 P/Share
|
Sep 11
2019
|
Tyndall Capital Partners L P > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
1,247
-0.16%
|
$2,494
$2.75 P/Share
|
Sep 09
2019
|
Tyndall Capital Partners L P > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
400
-0.05%
|
$800
$2.77 P/Share
|
Sep 06
2019
|
Tyndall Capital Partners L P > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
5,015
-0.63%
|
$10,030
$2.78 P/Share
|
Sep 05
2019
|
Tyndall Capital Partners L P > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
400
-0.05%
|
$800
$2.75 P/Share
|
Jul 10
2019
|
Tyndall Capital Partners L P > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
5,484
-0.34%
|
$10,968
$2.81 P/Share
|
Jul 09
2019
|
Tyndall Capital Partners L P > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
16,370
-1.01%
|
$32,740
$2.84 P/Share
|